BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36631026)

  • 1. Evaluation of Five User-Friendly Whole Genome Sequencing Software for
    Kim N; Seok KH; Shin S; Kim B; Park H; Roh EY; Yoon JH; Shin S
    J Korean Med Sci; 2022 Nov; 37(46):e328. PubMed ID: 36631026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
    Vīksna A; Sadovska D; Berge I; Bogdanova I; Vaivode A; Freimane L; Norvaiša I; Ozere I; Ranka R
    BMC Infect Dis; 2023 Sep; 23(1):638. PubMed ID: 37770850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
    Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
    Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance.
    Park M; Lalvani A; Satta G; Kon OM
    BMC Infect Dis; 2022 Apr; 22(1):349. PubMed ID: 35392842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of AAICare®-TB sequence analysis tool for accurate diagnosis of drug-resistant tuberculosis: A comparative study with TB-Profiler and Mykrobe.
    Singhal R; Hingane S; Bhalla M; Sharma A; Ferdosh S; Tiwari A; Jayaswal P; Yadav RN; Arora J; Dewan RK; Sharma S
    Tuberculosis (Edinb); 2024 Jul; 147():102515. PubMed ID: 38744006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
    Morey-León G; Mejía-Ponce PM; Granda Pardo JC; Muñoz-Mawyin K; Fernández-Cadena JC; García-Moreira E; Andrade-Molina D; Licona-Cassani C; Berná L
    PLoS One; 2023; 18(12):e0294670. PubMed ID: 38051742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.
    Chaidir L; Ruesen C; Dutilh BE; Ganiem AR; Andryani A; Apriani L; Huynen MA; Ruslami R; Hill PC; van Crevel R; Alisjahbana B
    J Glob Antimicrob Resist; 2019 Mar; 16():170-177. PubMed ID: 30172045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania.
    Katale BZ; Mbelele PM; Lema NA; Campino S; Mshana SE; Rweyemamu MM; Phelan JE; Keyyu JD; Majigo M; Mbugi EV; Dockrell HM; Clark TG; Matee MI; Mpagama S
    BMC Genomics; 2020 Feb; 21(1):174. PubMed ID: 32085703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome sequencing analysis of multidrug-resistant
    Tania T; Sudarmono P; Kusumawati RL; Rukmana A; Pratama WA; Regmi SM; Kaewprasert O; Chaiprasert A; Chongsuvivatwong V; Faksri K
    J Med Microbiol; 2020 Jul; 69(7):1013-1019. PubMed ID: 32579102
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data.
    Sharma MK; Stobart M; Akochy PM; Adam H; Janella D; Rabb M; Alawa M; Sekirov I; Tyrrell GJ; Soualhine H
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of drug susceptibility profile of Mycobacterium tuberculosis Lineage 1 from Brazil based on whole genome sequencing and phenotypic methods.
    Guimarães AEDS; Sharma A; Furlaneto IP; Rutaihwa L; Cardoso JF; da Conceição ML; Spinassé LB; Machado E; Lopes ML; Duarte RS; Gagneux S; Suffys PN; Lima KVB; Conceição EC
    Mem Inst Oswaldo Cruz; 2021; 115():e200520. PubMed ID: 33533871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learning.
    Gröschel MI; Owens M; Freschi L; Vargas R; Marin MG; Phelan J; Iqbal Z; Dixit A; Farhat MR
    Genome Med; 2021 Aug; 13(1):138. PubMed ID: 34461978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates collected in the Czech Republic, 2005-2020.
    Dohál M; Dvořáková V; Šperková M; Pinková M; Spitaleri A; Norman A; Cabibbe AM; Rasmussen EM; Porvazník I; Škereňová M; Solovič I; Cirillo DM; Mokrý J
    Sci Rep; 2022 May; 12(1):7149. PubMed ID: 35505072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
    Heyckendorf J; Andres S; Köser CU; Olaru ID; Schön T; Sturegård E; Beckert P; Schleusener V; Kohl TA; Hillemann D; Moradigaravand D; Parkhill J; Peacock SJ; Niemann S; Lange C; Merker M
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversified lineages and drug-resistance profiles of clinical isolates of
    Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
    Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic factors associated with acquired phenotypic drug resistance and its compensatory evolution during tuberculosis treatment.
    Zhang G; Sun X; Fleming J; Ran F; Luo J; Chen H; Ju H; Wang Z; Zhao H; Wang C; Zhang F; Dai X; Yang X; Li C; Liu Y; Wang Y; Zhang X; Jiang Y; Wu Z; Bi L; Zhang H
    Clin Microbiol Infect; 2024 May; 30(5):637-645. PubMed ID: 38286176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
    PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole genome sequencing of clinical strains of Mycobacterium tuberculosis from Mumbai, India: A potential tool for determining drug-resistance and strain lineage.
    Chatterjee A; Nilgiriwala K; Saranath D; Rodrigues C; Mistry N
    Tuberculosis (Edinb); 2017 Dec; 107():63-72. PubMed ID: 29050774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.